| Year |
Citation |
Score |
| 2021 |
Herberg S, Varghai D, Alt DS, Dang PN, Park H, Cheng Y, Shin JY, Dikina AD, Boerckel JD, Rolle MW, Alsberg E. Scaffold-free human mesenchymal stem cell construct geometry regulates long bone regeneration. Communications Biology. 4: 89. PMID 33469154 DOI: 10.1038/s42003-020-01576-y |
0.799 |
|
| 2019 |
Herberg S, McDermott AM, Dang PN, Alt DS, Tang R, Dawahare JH, Varghai D, Shin JY, McMillan A, Dikina AD, He F, Lee YB, Cheng Y, Umemori K, Wong PC, et al. Combinatorial morphogenetic and mechanical cues to mimic bone development for defect repair. Science Advances. 5: eaax2476. PMID 31489377 DOI: 10.1126/Sciadv.Aax2476 |
0.806 |
|
| 2019 |
Khalil AS, Yu X, Dang PN, Alsberg E, Murphy WL. A Microparticle Approach for Non-viral Gene Delivery within 3D Human Mesenchymal Stromal Cell Aggregates. Acta Biomaterialia. PMID 31004846 DOI: 10.1016/J.Actbio.2019.04.038 |
0.636 |
|
| 2018 |
Nguyen MK, Jeon O, Dang PN, Huynh CT, Varghai D, Riazi H, McMillan A, Herberg S, Alsberg E. RNA interfering molecule delivery from in situ forming biodegradable hydrogels for enhancement of bone formation in rat calvarial bone defects. Acta Biomaterialia. PMID 29885529 DOI: 10.1016/J.Actbio.2018.06.007 |
0.797 |
|
| 2018 |
Herberg S, Varghai D, Cheng Y, Dikina AD, Dang PN, Rolle MW, Alsberg E. High-density human mesenchymal stem cell rings with spatiotemporally-controlled morphogen presentation as building blocks for engineering bone diaphyseal tissue. Nanotheranostics. 2: 128-143. PMID 29577017 DOI: 10.7150/ntno.23354 |
0.845 |
|
| 2017 |
Dang PN, Herberg S, Varghai D, Riazi H, Varghai D, McMillan A, Awadallah A, Phillips LM, Jeon O, Nguyen MK, Dwivedi N, Yu X, Murphy WL, Alsberg E. Endochondral Ossification in Critical-Sized Bone Defects via Readily Implantable Scaffold-Free Stem Cell Constructs. Stem Cells Translational Medicine. 6: 1644-1659. PMID 28661587 DOI: 10.1002/Sctm.16-0222 |
0.857 |
|
| 2016 |
Dang PN, Dwivedi N, Yu X, Phillips L, Bowerman C, Murphy WL, Alsberg E. Guiding Chondrogenesis and Osteogenesis with Mineral-Coated Hydroxyapatite and BMP-2 Incorporated within High-Density hMSC Aggregates for Bone Regeneration. Acs Biomaterials Science & Engineering. 2: 30-42. PMID 33418642 DOI: 10.1021/Acsbiomaterials.5B00277 |
0.732 |
|
| 2016 |
Dang PN, Dwivedi N, Yu X, Phillips L, Bowerman C, Murphy WL, Alsberg E. Guiding Chondrogenesis and Osteogenesis with Mineral-Coated Hydroxyapatite and BMP-2 Incorporated within High-Density hMSC Aggregates for Bone Regeneration Acs Biomaterial Science and Engineering. 2: 30-42. DOI: 10.1021/acsbiomaterials.5b00277 |
0.564 |
|
| 2015 |
Dang PN, Dwivedi N, Phillips LM, Yu X, Herberg S, Bowerman C, Solorio LD, Murphy WL, Alsberg E. Controlled Dual Growth Factor Delivery From Microparticles Incorporated Within Human Bone Marrow-Derived Mesenchymal Stem Cell Aggregates for Enhanced Bone Tissue Engineering via Endochondral Ossification. Stem Cells Translational Medicine. PMID 26702127 DOI: 10.5966/Sctm.2015-0115 |
0.858 |
|
| 2015 |
Solorio LD, Phillips LM, McMillan A, Cheng CW, Dang PN, Samorezov JE, Yu X, Murphy WL, Alsberg E. Spatially Organized Differentiation of Mesenchymal Stem Cells within Biphasic Microparticle-Incorporated High Cell Density Osteochondral Tissues. Advanced Healthcare Materials. PMID 26371790 DOI: 10.1002/Adhm.201500598 |
0.739 |
|
| 2014 |
Yu X, Khalil A, Dang PN, Alsberg E, Murphy WL. Multilayered Inorganic Microparticles for Tunable Dual Growth Factor Delivery. Advanced Functional Materials. 24: 3082-3093. PMID 25342948 DOI: 10.1002/Adfm.201302859 |
0.613 |
|
| 2014 |
Dang PN, Solorio LD, Alsberg E. Driving cartilage formation in high-density human adipose-derived stem cell aggregate and sheet constructs without exogenous growth factor delivery. Tissue Engineering. Part A. 20: 3163-75. PMID 24873753 DOI: 10.1089/Ten.Tea.2012.0551 |
0.834 |
|
| 2013 |
Nguyen K, Dang PN, Alsberg E. Functionalized, biodegradable hydrogels for control over sustained and localized siRNA delivery to incorporated and surrounding cells. Acta Biomaterialia. 9: 4487-95. PMID 22902819 DOI: 10.1016/J.Actbio.2012.08.012 |
0.568 |
|
| 2012 |
Solorio LD, Dhami CD, Dang PN, Vieregge EL, Alsberg E. Spatiotemporal regulation of chondrogenic differentiation with controlled delivery of transforming growth factor-β1 from gelatin microspheres in mesenchymal stem cell aggregates. Stem Cells Translational Medicine. 1: 632-9. PMID 23197869 DOI: 10.5966/Sctm.2012-0039 |
0.822 |
|
| 2012 |
Solorio LD, Vieregge EL, Dhami CD, Dang PN, Alsberg E. Engineered cartilage via self-assembled hMSC sheets with incorporated biodegradable gelatin microspheres releasing transforming growth factor-β1. Journal of Controlled Release : Official Journal of the Controlled Release Society. 158: 224-32. PMID 22100386 DOI: 10.1016/J.Jconrel.2011.11.003 |
0.83 |
|
| 2009 |
Oliver AE, Ngassam V, Dang P, Sanii B, Wu H, Yee CK, Yeh Y, Parikh AN. Cell attachment behavior on solid and fluid substrates exhibiting spatial patterns of physical properties. Langmuir : the Acs Journal of Surfaces and Colloids. 25: 6992-6. PMID 19453187 DOI: 10.1021/La900166U |
0.305 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Dang PA, Palomino-Durand C, Elsafi Mabrouk M, Marquaille P, Odier C, Norvez S, Pauthe E, Corté L. Rational formulation design of injectable thermosensitive chitosan-based hydrogels for cell encapsulation and delivery. Carbohydrate Polymers. 277: 118836. PMID 34893253 DOI: 10.1016/j.carbpol.2021.118836 |
0.18 |
|
| 2019 |
Pagani IS, Dang P, Saunders VA, Grose R, Shanmuganathan N, Kok CH, Carne L, Rwodzi Z, Watts S, McLean J, Braley J, Altamura H, Yeung DT, Branford S, Yong ASM, et al. Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission. Leukemia. PMID 31768016 DOI: 10.1038/s41375-019-0647-x |
0.1 |
|
| 2019 |
Kok CH, Yeung DT, Lu L, Watkins DB, Leclercq TM, Dang P, Saunders VA, Reynolds J, White DL, Hughes TP. Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib. Blood Advances. 3: 1610-1621. PMID 31126916 DOI: 10.1182/bloodadvances.2019000195 |
0.095 |
|
| 2022 |
Rios-Vicil CI, Barbery D, Dang P, Jean WC. Single-stage cranioplasty with customized polyetheretherketone implant after tumor resection using virtual reality and augmented reality for precise implant customization and placement: illustrative case. Journal of Neurosurgery. Case Lessons. 3: CASE2255. PMID 35734232 DOI: 10.3171/CASE2255 |
0.093 |
|
| 2010 |
White DL, Dang P, Engler J, Frede A, Zrim S, Osborn M, Saunders VA, Manley PW, Hughes TP. Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with imatinib. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2761-7. PMID 20421539 DOI: 10.1200/JCO.2009.26.5819 |
0.093 |
|
| 2018 |
Eadie LN, Dang P, Goyne JM, Hughes TP, White DL. ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells. Plos One. 13: e0192180. PMID 29385210 DOI: 10.1371/journal.pone.0192180 |
0.093 |
|
| 2017 |
Wang J, Lu L, Kok CH, Saunders VA, Goyne JM, Dang P, Leclercq TM, Hughes TP, White DL. Increased peroxisome proliferator-activated receptor-gamma activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells. Haematologica. PMID 28154092 DOI: 10.3324/haematol.2016.153270 |
0.089 |
|
| 2023 |
Pagani IS, Shanmuganathan N, Dang P, Saunders VA, Grose R, Kok CH, James J, Tolland M, Braley JA, Altamura HK, Yeung DT, Branford S, Yong AS, Hughes TP, Ross DM. Lineage-specific detection of residual disease predicts relapse in chronic myeloid leukemia patients stopping therapy. Blood. PMID 37616555 DOI: 10.1182/blood.2023021119 |
0.088 |
|
| 2018 |
Pagani IS, Dang P, Kommers IO, Goyne JM, Nicola M, Saunders VA, Braley J, White DL, Yeung DT, Branford S, Hughes TP, Ross DM. BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia. Haematologica. PMID 29976745 DOI: 10.3324/haematol.2018.189787 |
0.083 |
|
| 2018 |
Ross DM, Pagani IS, Shanmuganathan N, Kok CH, Seymour JF, Mills AK, Filshie RJ, Arthur CK, Dang P, Saunders VA, Braley J, Yong AS, Yeung DT, White DL, Grigg AP, et al. Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells. Leukemia. PMID 30315232 DOI: 10.1038/s41375-018-0264-0 |
0.065 |
|
| 2020 |
Still CH, Dang PB, Malaker D, Peavy TD. The Design and Rationale of a Pilot Study: A COmmunity and Tech-Based ApproaCh for Hypertension Self-MANagement (COACHMAN). Journal of National Black Nurses' Association : Jnbna. 31: 52-59. PMID 32853497 |
0.064 |
|
| 2020 |
Nguyen HT, Duong TQ, Nguyen LD, Vo TQN, Tran NT, Dang PDN, Nguyen LD, Dang CK, Nguyen LK. Development of a Spatial Decision Support System for Real-Time Flood Early Warning in the Vu Gia-Thu Bon River Basin, Quang Nam Province, Vietnam. Sensors (Basel, Switzerland). 20. PMID 32192135 DOI: 10.3390/s20061667 |
0.061 |
|
| 2017 |
Dang PT, Le HG, Hoang VT, Tran HTH, Dao CD, Nguyen KT, Le GH, Nguyen QK, Nguyen TV, Vu TA. Immobilization of D-Amino Acid Oxidase (DAAO) Enzyme on Hybrid Mesoporous MCF, SBA-15 and MCM-41 Nanomaterial. Journal of Nanoscience and Nanotechnology. 17: 947-53. PMID 29671483 |
0.061 |
|
| 2016 |
Andrews KW, Roseland JM, Gusev PA, Palachuvattil J, Dang PT, Savarala S, Han F, Pehrsson PR, Douglass LW, Dwyer JT, Betz JM, Saldanha LG, Bailey RL. Analytical ingredient content and variability of adult multivitamin/mineral products: national estimates for the Dietary Supplement Ingredient Database. The American Journal of Clinical Nutrition. PMID 27974309 DOI: 10.3945/Ajcn.116.134544 |
0.059 |
|
| 2023 |
Kok CH, Saunders VA, Dang P, Shanmuganathan N, White D, Branford S, Yeung D, Hughes TP. Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib. Blood Cancer Journal. 13: 143. PMID 37696829 DOI: 10.1038/s41408-023-00917-4 |
0.056 |
|
| 2017 |
Sadras T, Heatley SL, Kok CH, Dang P, Galbraith KM, McClure BJ, Muskovic W, Venn NC, Moore S, Osborn M, Revesz T, Moore AS, Hughes TP, Yeung D, Sutton R, et al. Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions. Cancer Letters. PMID 28866095 DOI: 10.1016/j.canlet.2017.08.034 |
0.055 |
|
| 2023 |
Huang Y, Liao Z, Dang P, Queen S, Abreu CM, Gololobova O, Zheng L, Witwer KW. Longitudinal characterization of circulating extracellular vesicles and small RNA during simian immunodeficiency virus infection and antiretroviral therapy. Aids (London, England). PMID 36779477 DOI: 10.1097/QAD.0000000000003487 |
0.053 |
|
| 2008 |
Hiwase DK, Saunders V, Hewett D, Frede A, Zrim S, Dang P, Eadie L, To LB, Melo J, Kumar S, Hughes TP, White DL. Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3881-8. PMID 18559609 DOI: 10.1158/1078-0432.CCR-07-5095 |
0.051 |
|
| 2013 |
Ross DM, Branford S, Seymour JF, Schwarer AP, Arthur C, Yeung DT, Dang P, Goyne JM, Slader C, Filshie RJ, Mills AK, Melo JV, White DL, Grigg AP, Hughes TP. Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study. Blood. 122: 515-22. PMID 23704092 DOI: 10.1182/blood-2013-02-483750 |
0.044 |
|
| 2006 |
White DL, Saunders VA, Dang P, Engler J, Zannettino AC, Cambareri AC, Quinn SR, Manley PW, Hughes TP. OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib. Blood. 108: 697-704. PMID 16597591 DOI: 10.1182/blood-2005-11-4687 |
0.043 |
|
| 2020 |
Still CH, Margevicius S, Harwell C, Huang MC, Martin L, Dang PB, Wright Jnr JT. A Community and Technology-Based Approach for Hypertension Self-Management (COACHMAN) to Improve Blood Pressure Control in African Americans: Results from a Pilot Study. Patient Preference and Adherence. 14: 2301-2313. PMID 33262580 DOI: 10.2147/PPA.S283086 |
0.043 |
|
| 2012 |
White DL, Radich J, Soverini S, Saunders VA, Frede AK, Dang P, Cilloni D, Lin P, Mongay L, Woodman R, Manley P, Slader C, Kim DW, Pane F, Martinelli G, et al. Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib. Haematologica. 97: 907-14. PMID 22207690 DOI: 10.3324/haematol.2011.056457 |
0.042 |
|
| 2021 |
Yanni DS, Ozgur BM, Louis RG, Shekhtman Y, Iyer RR, Boddapati V, Iyer A, Patel PD, Jani R, Cummock M, Herur-Raman A, Dang P, Goldstein IM, Brant-Zawadzki M, Steineke T, et al. Real-time navigation guidance with intraoperative CT imaging for pedicle screw placement using an augmented reality head-mounted display: a proof-of-concept study. Neurosurgical Focus. 51: E11. PMID 34333483 DOI: 10.3171/2021.5.FOCUS21209 |
0.041 |
|
| 2022 |
Van Le D, Nguyen MB, Dang PT, Lee T, Nguyen TD. Synthesis of a UiO-66/g-CN composite using terephthalic acid obtained from waste plastic for the photocatalytic degradation of the chemical warfare agent simulant, methyl paraoxon. Rsc Advances. 12: 22367-22376. PMID 36105971 DOI: 10.1039/d2ra03483b |
0.041 |
|
| 2019 |
Ross DM, Pagani IS, Irani YD, Clarson J, Leclercq T, Dang P, McLean J, Saunders VA, Carne L, Reynolds J, Ritchie DS, White DL, Branford S, Hughes TP, Yong ASM. Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia. British Journal of Haematology. PMID 30916385 DOI: 10.1111/bjh.15894 |
0.04 |
|
| 2022 |
Lu L, Kok CH, Dang P, Branford S, Saunders VA, Shanmuganathan N, Ross DM, Hughes TP, Yeung DTO. Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment-free remission. British Journal of Haematology. PMID 35620965 DOI: 10.1111/bjh.18277 |
0.04 |
|
| 2007 |
White DL, Saunders VA, Dang P, Engler J, Venables A, Zrim S, Zannettino A, Lynch K, Manley PW, Hughes T. Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity. Blood. 110: 4064-72. PMID 17761829 DOI: 10.1182/Blood-2007-06-093617 |
0.037 |
|
| 2022 |
Tiong IS, Andrieska N, Dang P, Jones K, Thompson E, McBean M, Blombery P. Clinically relevant variation in FLT3-ITD quantitation as a result of PCR cycle number and ITD insertion size. Pathology. PMID 36153154 DOI: 10.1016/j.pathol.2022.07.004 |
0.03 |
|
| 2022 |
Pham TT, Tang HTK, Nguyen NTK, Dang PH, Nguyen ATV, Nguyen ATT, Tran HNM, Hoang LT, Tran DNL, Nguyen QN. COVID-19 impacts, opportunities and challenges for wildlife farms in Binh Duong and Ba Ria Vung Tau, Vietnam. Global Ecology and Conservation. 40: e02314. PMID 36312591 DOI: 10.1016/j.gecco.2022.e02314 |
0.029 |
|
| 2018 |
Andrews KW, Gusev PA, McNeal M, Savarala S, Dang PTV, Oh L, Atkinson R, Pehrsson PR, Dwyer JT, Saldanha LG, Betz JM, Costello RB, Douglass LW. Dietary Supplement Ingredient Database (DSID) and the Application of Analytically Based Estimates of Ingredient Amount to Intake Calculations. The Journal of Nutrition. 148: 1413S-1421S. PMID 31505677 DOI: 10.1093/Jn/Nxy092 |
0.029 |
|
| 2017 |
Heatley SL, Sadras T, Kok CH, Nievergall E, Quek K, Dang P, McClure B, Venn N, Moore S, Suttle J, Law T, Ng A, Muskovic W, Norris MD, Revesz T, et al. High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment. Haematologica. PMID 28935844 DOI: 10.3324/Haematol.2016.162925 |
0.028 |
|
| 2020 |
Pagani IS, Dang P, Saunders VA, Braley J, Thieleke A, Branford S, Hughes TP, Ross DM. Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 transcripts in chronic myeloid leukemia. Leukemia & Lymphoma. 1-3. PMID 32508223 DOI: 10.1080/10428194.2020.1772476 |
0.017 |
|
| 2022 |
Tigchelaar SS, Medress ZA, Quon J, Dang P, Barbery D, Bobrow A, Kin C, Louis R, Desai A. Augmented reality neuronavigation for en bloc resection of spinal column lesions. World Neurosurgery. PMID 36096393 DOI: 10.1016/j.wneu.2022.08.143 |
0.013 |
|
| 2022 |
Lee JJ, Klepcha M, Wong M, Dang PN, Sadrameli SS, Britz GW. The First Pilot Study of an Interactive, 360° Augmented Reality Visualization Platform for Neurosurgical Patient Education: A Case Series. Operative Neurosurgery (Hagerstown, Md.). PMID 35404334 DOI: 10.1227/ons.0000000000000186 |
0.012 |
|
| 2022 |
Castellanos JM, Barbery D, Yefimov A, Dang PN. Preoperative planning using virtual reality for percutaneous transseptal valve-in-valve transcatheter mitral valve replacement: a case report. European Heart Journal. Case Reports. 6: ytac384. PMID 36285227 DOI: 10.1093/ehjcr/ytac384 |
0.01 |
|
| Hide low-probability matches. |